Moderna (MRNA) IV into COVID-19 vaccine boosters get FDA authorization
Moderna (NASDAQ: MRNA) 30-day option implied volatility is at 60; compared to its 52-week range of 51 to 131 into MRNA & Johnson & Johnson (JNJ) COVID-19 vaccine boosters get FDA authorization.
